Found: 49
Select item for more details and to access through your institution.
Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
- Published in:
- 2010
- By:
- Publication type:
- journal article
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma.
- Published in:
- Human Genomics, 2016, v. 10, p. 1, doi. 10.1186/s40246-016-0096-9
- By:
- Publication type:
- Article
Comparing the 2017 ASCO/CAP guideline for gastroesophageal adenocarcinoma surgical specimen to the 2018 ASCO/CAP guideline for breast cancer in assessing the HER2 status in primary mucinous ovarian carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 5, p. 1023, doi. 10.1007/s00428-022-03285-9
- By:
- Publication type:
- Article
The HER2 gene copies per tumor cell either before or after correction for chromosome-17 correlated significantly with HER2 IHC results in epithelial ovarian cancer in a tissue microarray study.
- Published in:
- Archives of Gynecology & Obstetrics, 2011, v. 284, n. 3, p. 721, doi. 10.1007/s00404-010-1708-6
- By:
- Publication type:
- Article
A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16<sup>INK4a</sup>) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
- Published in:
- Archives of Gynecology & Obstetrics, 2010, v. 281, n. 5, p. 845, doi. 10.1007/s00404-009-1151-8
- By:
- Publication type:
- Article
Comparing the scoring mechanisms of p16<sup>INK4a</sup> immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
- Published in:
- Archives of Gynecology & Obstetrics, 2010, v. 281, n. 2, p. 293, doi. 10.1007/s00404-009-1094-0
- By:
- Publication type:
- Article
Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
- Published in:
- Archives of Gynecology & Obstetrics, 2010, v. 281, n. 2, p. 317, doi. 10.1007/s00404-009-1115-z
- By:
- Publication type:
- Article
Ancillary p16<sup>INK4a</sup> adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
- Published in:
- Archives of Gynecology & Obstetrics, 2009, v. 280, n. 3, p. 405, doi. 10.1007/s00404-008-0859-1
- By:
- Publication type:
- Article
Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: “Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma”, in J Cutan Pathol 2009; 36: 543
- Published in:
- Journal of Cutaneous Pathology, 2010, v. 37, n. 10, p. 1123, doi. 10.1111/j.1600-0560.2010.01514.x
- By:
- Publication type:
- Article
Anti-cytokeratin CAM5.2 reagent (Becton Dickinson Biosciences) can detect CK 8, not CK8/18-Comment on "Sonographic findings in a patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor," J Clin Ultrasound 2010 Jan 20 [Epub ahead of print].
- Published in:
- 2010
- By:
- Publication type:
- Letter
Monoclonal antibody CAM5.2 can detect the cytokeratin 8, not cytokeratin 18. Comment on: “Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance. Langenbecks Arch Surg. 2009 Jan; 394(1): 105-113.”
- Published in:
- 2010
- By:
- Publication type:
- Letter
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 3, p. 337, doi. 10.1515/CCLM.2010.082
- By:
- Publication type:
- Article
Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2008, v. 46, n. 7, p. 997, doi. 10.1515/CCLM.2008.196
- By:
- Publication type:
- Article
Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on 'Early Assessment of Axillary Response with F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: Implications for Surgical Management of the Axilla. Annals of Surgical Oncology doi: 10.1245/s10434-013-2902-0 (2013)'
- Published in:
- 2014
- By:
- Publication type:
- Letter
Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients
- Published in:
- 2011
- By:
- Publication type:
- Letter
Identification of the Coexisting HER2 Gene Amplification and Novel Mutations in the HER2 Protein-Overexpressed Mucinous Epithelial Ovarian Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 8, p. 2388, doi. 10.1245/s10434-011-1572-z
- By:
- Publication type:
- Article
Anti-Cytokeratin CAM 5.2 (Becton Dickinson) is not synonymous with CK8/18 monoclonal antibody. Comment on “Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 42:167–174”
- Published in:
- 2010
- By:
- Publication type:
- Letter
BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142135
- By:
- Publication type:
- Article
A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ——— CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.
- Published in:
- Diagnostic Pathology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13000-015-0438-2
- By:
- Publication type:
- Article
A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ——— CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.
- Published in:
- Diagnostic Pathology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13000-015-0438-2
- By:
- Publication type:
- Article
Identification and typing of human papillomavirus in cervical cancers in Taiwan.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD).
- Published in:
- 2011
- By:
- Publication type:
- Letter
Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: Frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.
- Published in:
- Journal of Medical Virology, 1996, v. 49, n. 1, p. 15, doi. 10.1002/(SICI)1096-9071(199605)49:1<15::AID-JMV3>3.0.CO;2-N
- By:
- Publication type:
- Article
CAM 5.2 shows specific reactivity for cytokeratin 8, but less strict reactivity for cytokeratin 7 and no reactivity for cytokeratin 18: in response to 'Fujikawa T, Tanaka A, Abe T et al. 'Undifferentiated carcinoma of the common bile duct with intraductal tumor thrombi: report of a case'. Surg Today 2011;41(4):579-84.'
- Published in:
- Surgery Today, 2013, v. 43, n. 10, p. 1206, doi. 10.1007/s00595-013-0600-y
- By:
- Publication type:
- Article
Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
- Published in:
- Reproductive Sciences, 2018, v. 25, n. 1, p. 86, doi. 10.1177/1933719117702250
- By:
- Publication type:
- Article
Single-Nucleotide Polymorphisms and Haplotypes of Membrane Type 1-Matrix Metalloproteinase in Susceptibility and Clinical Significance of Squamous Cell Neoplasia of Uterine Cervix in Taiwan Women.
- Published in:
- Reproductive Sciences, 2012, v. 19, n. 9, p. 932, doi. 10.1177/1933719112438445
- By:
- Publication type:
- Article
Significant Relation of Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Combination With Matrix Metalloproteinase-2 to Survival of Patients With Cancer of Uterine Cervix.
- Published in:
- Reproductive Sciences, 2011, v. 18, n. 8, p. 798, doi. 10.1177/1933719111398143
- By:
- Publication type:
- Article
Polymorphisms of Human Nonmetastatic Clone 23 Type 1 Gene and Neoplastic Lesions of Uterine Cervix.
- Published in:
- Reproductive Sciences, 2010, v. 17, n. 10, p. 886, doi. 10.1177/1933719110373661
- By:
- Publication type:
- Article
Evaluation of Matrix Metalloproteinase-2 Expression in Cervical Carcinogenesis Using Tissue Array and Integrated Optical Density for Immunoreactivity.
- Published in:
- Reproductive Sciences, 2007, v. 14, n. 7, p. 719, doi. 10.1177/1933719107307537
- By:
- Publication type:
- Article
Human Nonmetastatic Clone 23 Type 1 Gene Suppresses Migration of Cervical Cancer Cells and Enhances the Migration Inhibition of Fungal Immunomodulatory Protein From Ganoderma tsugae.
- Published in:
- Reproductive Sciences, 2007, v. 14, n. 5, p. 475, doi. 10.1177/1933719107305035
- By:
- Publication type:
- Article
High Expression of Human Telomerase Reverse Transcriptase in High-Grade Intraepithelial Neoplasia and Carcinoma of Uterine Cervix and Its Correlation With Human Papillomavirus Infection.
- Published in:
- Reproductive Sciences, 2007, v. 14, n. 4, p. 338, doi. 10.1177/1933719107303986
- By:
- Publication type:
- Article
Unusual c-KIT (+) squamous cell carcinoma of uterine cervix showing remarkable platelet-derived growth factor receptor, alpha subunit expression, but no activating mutation.
- Published in:
- Histopathology, 2011, v. 59, n. 4, p. 788, doi. 10.1111/j.1365-2559.2011.03956.x
- By:
- Publication type:
- Article
Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.
- Published in:
- Histopathology, 2011, v. 58, n. 6, p. 988, doi. 10.1111/j.1365-2559.2011.03849.x
- By:
- Publication type:
- Article
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target Correspondence.
- Published in:
- Histopathology, 2010, v. 57, n. 5, p. 763, doi. 10.1111/j.1365-2559.2010.03689.x
- By:
- Publication type:
- Article
Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: ‘Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma’. Histopathology 2009; 54; 607–613
- Published in:
- 2010
- By:
- Publication type:
- Letter
Significant Association of Elevated Concentration of Plasma YKL-40 with Disease Severity in Patients With Pelvic Inflammatory Disease.
- Published in:
- Journal of Clinical Laboratory Analysis, 2012, v. 26, n. 3, p. 136, doi. 10.1002/jcla.21500
- By:
- Publication type:
- Article
HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, v. 397, n. 10, p. 7615, doi. 10.1007/s00210-024-03066-y
- By:
- Publication type:
- Article
Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Anti-cytokeratin CAM5.2 should not be mistaken for cytokeratin 8/18 monoclonal antibody: Comment on 'Spindle cell squamous cell carcinoma not expressing stratified but simple epithelial cytokeratin: Efficacy of simple epithelial cytokeratin immunoreactivity' (Tokuriki A, Kiyohara T, Kouraba S, Kumakiri M, Journal of Dermatology 2012; 39: 72-75) Anti-cytokeratin CAM5.2 should not be mistaken for cytokeratin 8/18 monoclonal antibody: Comment on 'Spindle cell squamous cell carcinoma not expressing stratified but simple epithelial cytokeratin: Efficacy of simple epithelial cytokeratin immunoreactivity' (Tokuriki A, Kiyohara T, Kouraba S, Kumakiri M, Journal of Dermatology 2012; 39: 72-75)
- Published in:
- Journal of Dermatology, 2012, v. 39, n. 12, p. 1110, doi. 10.1111/j.1346-8138.2012.01650.x
- By:
- Publication type:
- Article
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study
- Published in:
- Journal of Translational Medicine, 2009, v. 7, p. 1, doi. 10.1186/1479-5876-7-37
- By:
- Publication type:
- Article
Scoring mechanisms of p16<sup>INK4a</sup> immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study
- Published in:
- Journal of Translational Medicine, 2009, v. 7, p. 1, doi. 10.1186/1479-5876-7-25
- By:
- Publication type:
- Article
Both Kras gene mutation and Her2 gene mutation tend to exist in an inverse manner but not mutually exclusive in mucinous ovarian carcinoma: An analysis of 21 taiwanese women.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, n. 3, p. 862, doi. 10.4103/jcrt.JCRT_1358_20
- By:
- Publication type:
- Article
Both gene mutation and gene mutation tend to exist in an inverse manner but not mutually exclusive in mucinous ovarian carcinoma: An analysis of 21 taiwanese women.
- Published in:
- 2022
- By:
- Publication type:
- Letter
p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 11, p. 2578, doi. 10.1002/cncr.26089
- By:
- Publication type:
- Article
Source of Anti-Cytokeratin CAM 5.2 Reagent.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Anti-Cytokeratin CAM 5.2 is Specific for K8 and to a Lesser Extent for the Closely Related K7, but Shows no Reactivity with K18 or K19.
- Published in:
- 2010
- By:
- Publication type:
- Letter